Literature DB >> 9452330

Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor.

G M Hariz1, A T Bergenheim, M I Hariz, M Lindberg.   

Abstract

Chronic thalamic stimulation (CTS) has a documented good effect on tremor in patients with Parkinson's disease (PD) and essential tremor (ET). This study evaluates whether the alleviation of impairment, i.e., tremor, translates into improvement of the patient's ability in performing instrumental activities of daily living (IADL). Thirteen patients were assessed with an occupational therapy tool called Assessment of Motor and Process Skills (AMPS). This observation-based scale rates the patient's motor and process skills needed to perform a given task. The evaluations were done at a mean of 13 months after surgery in the patient's home, and included assessments of IADL with the CTS activated and switched off, respectively. The results showed that most patients improved to variable degrees in their IADL ability when the thalamic stimulation was on. The improvement was more marked in patients operated on for tremor of their dominant hand. The improvement concerned mainly the skill items related to the patients' abilities of coordination, calibration, endurance, and accommodation during IADL task performance. The authors concluded that for some patients with tremor, CTS can improve independence in domestic activities of daily living.

Entities:  

Mesh:

Year:  1998        PMID: 9452330     DOI: 10.1002/mds.870130117

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  12 in total

1.  Impact of thalamic deep brain stimulation on disability and health-related quality of life in patients with essential tremor.

Authors:  G-M Hariz; M Lindberg; A T Bergenheim
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

2.  Essential Tremor.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

Review 3.  Deep brain stimulation for Parkinson's disease.

Authors:  Patricia Limousin; Irene Martinez-Torres
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

4.  Effects of DBS on precision grip abnormalities in essential tremor.

Authors:  Tristan M Stani; Kim J Burchiel; Melanie J Hart; David P Lenar; Valerie C Anderson
Journal:  Exp Brain Res       Date:  2009-10-21       Impact factor: 1.972

5.  Multicentre European study of thalamic stimulation in parkinsonian and essential tremor.

Authors:  P Limousin; J D Speelman; F Gielen; M Janssens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

Review 6.  Thalamic, subthalamic nucleus and internal pallidum stimulation in Parkinson's disease.

Authors:  P Limousin-Dowsey; P Pollak; N Van Blercom; P Krack; A Benazzouz; A Benabid
Journal:  J Neurol       Date:  1999-09       Impact factor: 4.849

7.  [Deep brain stimulation for Parkinson's disease. Consensus recommendations of the German Deep Brain Stimulation Association].

Authors:  R Hilker; R Benecke; G Deuschl; W Fogel; A Kupsch; C Schrader; F Sixel-Döring; L Timmermann; J Volkmann; M Lange
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 8.  Deep brain stimulation and tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

9.  STN vs. GPi deep brain stimulation for tremor suppression in Parkinson disease: A systematic review and meta-analysis.

Authors:  Joshua K Wong; James H Cauraugh; Kwo Wei David Ho; Matthew Broderick; Adolfo Ramirez-Zamora; Leonardo Almeida; Aparna Wagle Shukla; Christina A Wilson; Rob Ma de Bie; Frances M Weaver; Nyeonju Kang; Michael S Okun
Journal:  Parkinsonism Relat Disord       Date:  2018-08-28       Impact factor: 4.891

10.  Moving forward: advances in the treatment of movement disorders with deep brain stimulation.

Authors:  Terry K Schiefer; Joseph Y Matsumoto; Kendall H Lee
Journal:  Front Integr Neurosci       Date:  2011-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.